Biotech Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote “FOR” All Four of Dynavax’s Highly Qualified Director Nominees May 24, 2025
Biotech Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting May 23, 2025
Biotech Menarini Group Presents Updated Data Underscoring the Combinability of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2025 Annual Meeting May 23, 2025
Biotech EdgeCap-backed Comac Medical Group Expands with Acquisition of ILIFE Consulting, a French Early-phase Specialty CRO May 22, 2025
Biotech Aquaporin Q1 2025 Trading Statement – maintains full-year financial guidance for 2025 May 21, 2025
Biotech International and Regional Experts Focus on RSV Prevention at Pfizer MERA Maternal Immunization Summit: Born Ready May 21, 2025
Biotech Ascletis Announces First Participants Dosed in a U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity May 20, 2025
Biotech Minghui Pharmaceutical Announces First Patient Dosed in the Phase Ⅱ Combination Study of PD-1xVEGF Bispecific and TROP-2 ADC in Advanced NSCLC May 20, 2025
Biotech TCI Biotech to Unveil New Vision at Vitafoods Europe 2025: CDMO+, High-Absorption Innovation, and 45 Years of Scientific Leadership May 19, 2025